Incidence Rates and Case-Fatality Rates of Cerebral Vein Thrombosis: A Population-Based Study.


Journal

Stroke
ISSN: 1524-4628
Titre abrégé: Stroke
Pays: United States
ID NLM: 0235266

Informations de publication

Date de publication:
11 2021
Historique:
pubmed: 11 8 2021
medline: 8 1 2022
entrez: 10 8 2021
Statut: ppublish

Résumé

Cerebral vein thrombosis (CVT) incidence is estimated to be >10 per 1 000 000 per year. Few population-based studies investigating case-fatality rates (CFRs) and pyogenic/nonpyogenic CVT incidence are available. We assessed trends in CVT incidence between 2002 and 2012, as well as adjusted in-hospital CFRs and incidence of hospital admissions for pyogenic/nonpyogenic CVT in a large Northwestern Italian epidemiological study. Primary and secondary discharge diagnoses of pyogenic/nonpyogenic CVT were identified using International Classification of Diseases, Ninth Revision, Clinical Modification codes 325, 671.5, and 437.6. Age, sex, vital status at discharge, length of hospital stay, and up to 5 secondary discharge diagnoses were collected. Concomitant presence of intracerebral hemorrhage (ICH) was registered, and comorbidities were assessed through the Charlson comorbidity index. A total of 1718 patients were hospitalized for CVT (1147 females—66.8%; 810 pyogenic and 908 nonpyogenic CVT, 47.1% and 52.9%, respectively), with 134 patients (7.8%) experiencing a concomitant ICH. The overall incidence rate for CVT was 11.6 per 1 000 000 inhabitants with a sex-specific rate of 15.1 and 7.8 per 1 000 000 in females and males, respectively. CVT incidence significantly increased in women during time of observation (P=0.007), with the highest incidence being at 40 to 44 years (27.0 cases per 1 000 000). In-hospital CFR was 3%, with no difference between pyogenic/nonpyogenic CVT. Patients with concomitant ICH had a higher in-hospital CFR compared with patients without ICH (7.5% versus 2.7%; odds ratio, 2.96 [95% CI, 1.45–6.04]). In-hospital CFR progressively increased with increasing Charlson comorbidity index (P=0.003). Age (odds ratio, 1.03 [95% CI, 1.02–1.05]), Charlson comorbidity index ≥4 (odds ratio, 4.33 [95% CI, 1.29–14.52]), and ICH (odds ratio, 3.05 [95% CI, 1.40–6.62]) were independent predictors of in-hospital mortality. In a large epidemiological study, CVT incidence was found to be comparable to the one registered in population-based studies reported after the year 2000. CVT incidence increased among women over time. In-hospital CFR was low, but not negligible, in patients with concomitant ICH. Age, ICH, and a high number of comorbidities were independent predictors of in-hospital mortality. Pyogenic CVT was not a predictor of in-hospital CFR, although its high proportion was not confirmed by internal validation.

Sections du résumé

Background and Purpose
Cerebral vein thrombosis (CVT) incidence is estimated to be >10 per 1 000 000 per year. Few population-based studies investigating case-fatality rates (CFRs) and pyogenic/nonpyogenic CVT incidence are available. We assessed trends in CVT incidence between 2002 and 2012, as well as adjusted in-hospital CFRs and incidence of hospital admissions for pyogenic/nonpyogenic CVT in a large Northwestern Italian epidemiological study.
Methods
Primary and secondary discharge diagnoses of pyogenic/nonpyogenic CVT were identified using International Classification of Diseases, Ninth Revision, Clinical Modification codes 325, 671.5, and 437.6. Age, sex, vital status at discharge, length of hospital stay, and up to 5 secondary discharge diagnoses were collected. Concomitant presence of intracerebral hemorrhage (ICH) was registered, and comorbidities were assessed through the Charlson comorbidity index.
Results
A total of 1718 patients were hospitalized for CVT (1147 females—66.8%; 810 pyogenic and 908 nonpyogenic CVT, 47.1% and 52.9%, respectively), with 134 patients (7.8%) experiencing a concomitant ICH. The overall incidence rate for CVT was 11.6 per 1 000 000 inhabitants with a sex-specific rate of 15.1 and 7.8 per 1 000 000 in females and males, respectively. CVT incidence significantly increased in women during time of observation (P=0.007), with the highest incidence being at 40 to 44 years (27.0 cases per 1 000 000). In-hospital CFR was 3%, with no difference between pyogenic/nonpyogenic CVT. Patients with concomitant ICH had a higher in-hospital CFR compared with patients without ICH (7.5% versus 2.7%; odds ratio, 2.96 [95% CI, 1.45–6.04]). In-hospital CFR progressively increased with increasing Charlson comorbidity index (P=0.003). Age (odds ratio, 1.03 [95% CI, 1.02–1.05]), Charlson comorbidity index ≥4 (odds ratio, 4.33 [95% CI, 1.29–14.52]), and ICH (odds ratio, 3.05 [95% CI, 1.40–6.62]) were independent predictors of in-hospital mortality.
Conclusions
In a large epidemiological study, CVT incidence was found to be comparable to the one registered in population-based studies reported after the year 2000. CVT incidence increased among women over time. In-hospital CFR was low, but not negligible, in patients with concomitant ICH. Age, ICH, and a high number of comorbidities were independent predictors of in-hospital mortality. Pyogenic CVT was not a predictor of in-hospital CFR, although its high proportion was not confirmed by internal validation.

Identifiants

pubmed: 34372672
doi: 10.1161/STROKEAHA.121.034202
pmc: PMC10082066
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3578-3585

Références

Thromb Res. 2020 Dec;196:371-374
pubmed: 32979675
Acta Neurol Scand. 2008 Feb;117(2):117-21
pubmed: 18184347
J Clin Epidemiol. 1992 Jun;45(6):613-9
pubmed: 1607900
Adv Neurol. 2003;92:225-32
pubmed: 12760187
Stroke. 2012 Dec;43(12):3375-7
pubmed: 22996960
N Engl J Med. 2005 Apr 28;352(17):1791-8
pubmed: 15858188
QJM. 2002 Mar;95(3):137-42
pubmed: 11865168
JAMA Neurol. 2019 Dec 1;76(12):1457-1465
pubmed: 31479105
Stroke. 2012 Jan;43(1):262-4
pubmed: 21998058
Nat Rev Neurol. 2017 Sep;13(9):555-565
pubmed: 28820187
J Thromb Haemost. 2018 Apr;16(4):718-724
pubmed: 29341411
Curr Neurol Neurosci Rep. 2019 Aug 23;19(10):74
pubmed: 31440838
Cerebrovasc Dis. 2001;11(3):177-82
pubmed: 11306764
Stroke. 2004 Mar;35(3):664-70
pubmed: 14976332
Clin Neuropathol. 2001 May-Jun;20(3):101-5
pubmed: 11430492
Stroke. 2009 Jul;40(7):2356-61
pubmed: 19478226
PLoS Med. 2015 Oct 06;12(10):e1001885
pubmed: 26440803
Stroke. 2016 Sep;47(9):2180-2
pubmed: 27435401
Stroke. 1996 Feb;27(2):243-6
pubmed: 8571417
J Thromb Haemost. 2012 Jul;10(7):1297-302
pubmed: 22578023
J Stroke Cerebrovasc Dis. 2012 Jul;21(5):395-400
pubmed: 21367622
Stroke. 2012 Feb;43(2):e22; author reply e23
pubmed: 22246689
Blood. 2006 Aug 15;108(4):1129-34
pubmed: 16609071
Stroke. 2008 Oct;39(10):2707-11
pubmed: 18635853
Stroke. 2021 Jan;52(1):335-338
pubmed: 33272123
Stroke. 2005 Aug;36(8):1720-5
pubmed: 16002765
Lancet Neurol. 2007 Feb;6(2):162-70
pubmed: 17239803
J Stroke Cerebrovasc Dis. 2017 Aug;26(8):1848-1857
pubmed: 28583818

Auteurs

Emanuele Rezoagli (E)

Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy (E.R.).
Department of Emergency and Intensive Care, San Gerardo Hospital, Monza, Italy (E.R.).

Aldo Bonaventura (A)

Department of Internal Medicine, ASST Sette Laghi, Varese, Italy (A.B., A.V., V.G.).
First Clinic of Internal Medicine, Department of Internal Medicine, University of Genoa, Italy (A.B.).

Jonathan M Coutinho (JM)

Department of Neurology, Amsterdam University Medical Centers, University of Amsterdam, the Netherlands (J.M.C.).

Alessandra Vecchié (A)

Department of Internal Medicine, ASST Sette Laghi, Varese, Italy (A.B., A.V., V.G.).

Vera Gessi (V)

Department of Internal Medicine, ASST Sette Laghi, Varese, Italy (A.B., A.V., V.G.).

Roberta Re (R)

Presidio Ospedaliero S. Andrea, ASL VC, Vercelli, Italy (R.R.).

Alessandro Squizzato (A)

Medicine and Surgery (A.S.), University of Insubria, Varese/Como, Italy.

Fulvio Pomero (F)

Internal Medicine, Michele e Pietro Ferrero, Verduno, Cuneo, Italy (F.P.).

Matteo Bonzini (M)

Department of Clinical Sciences and Community Health, University of Milan, IRCCS Policlinico Fundation, Italy (M.B.).

Walter Ageno (W)

Department of Medicine and Surgery (W.A., F.D.), University of Insubria, Varese/Como, Italy.

Francesco Dentali (F)

Department of Medicine and Surgery (W.A., F.D.), University of Insubria, Varese/Como, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH